1. Pink Sheet
  2. >>Compliance
  3. >>Manufacturing

Reshoring Debate Continues As COVID-19 Drives New Wave Of US Drug Shortages

 
• By Shannon Brown

As the response to another wave of COVID-19 infections continues, fill rates of critical medicines such as methylprednisolone are dropping. But experts say the answer is not to concentrate manufacturing in US facilities, which could lead to further risks if US supply is disrupted.

COVID-19-related manufacturing has led to shortage of critical drugs • Source: Alamy

Fill rates of critical medicines are dropping as manufacturers focus resources on producing COVID-19-related vaccines, treatments and supplies, according to data from Premier Inc., a hospital group purchasing, consulting, and advocacy organization.

While drug shortage numbers fluctuate over the years due to various factors, Premier confirmed that of the 162 drugs currently on the US Food and Drug Administration’s shortage list, at least eight critical medications have

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Manufacturing

More from Compliance